Reward of merit,
talent and competence

Fighting for the Cure

Daybreak Children’s Rare Disease Fund grant-making supports the best research aimed at the cure of rare genetic diseases. Its primary beneficiaries are Fondazione Telethon Italia and its two world-class research centers, TIGEM and SR-TIGET.

Daybreak grants may sponsor specific scientific projects and may not sponsor general operating expenses of any organization.

Scientific Advisory Board

The Board of Directors is advised and supported in the selection of grantees by a Board of outstanding researchers.